Cutaneous wound healing: An update

被引:141
作者
Yamaguchi, Y [1 ]
Yoshikawa, K [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka 5650871, Japan
关键词
epithelial-mesenchymal interactions; re-epithelialization; granulation tissue formation; wound contraction; practical wound management;
D O I
10.1111/j.1346-8138.2001.tb00025.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Our understanding of wound-healing mechanisms has progressed over the past decade. Wound healing is traditionally divided into three phases-the inflammatory phase, the proliferation phase, and the remodeling phase- and involves a well-orchestrated interaction among blood vessels (platelets, macrophages, neutrophils, endothelial cells, and smooth muscle cells), epidermis (keratinocytes, melanocytes, and Langerhans cells), adnexal structures (outer root sheath cells and hair dermal papilla cells), dermis (fibroblasts and myofibroblasts), nervous system (neurons), and subcutaneous fatty layers (adipocytes). We review recent discoveries of basic and clinical aspects of wound healing including several revolutions that occurred in wound management: occlusive dressing therapy, use of living skin equivalents, and topical administration of growth factors. As we previously proposed, the use of tissue substitutes and autologous epidermal sheets led to a new concept of skin grafting through the keratinocyte activation phase in the graft healing mechanism. In this review, we also discuss a representative patient who presented with plantar wounds caused by calcaneal osteomyelitis and healed by the coverage of epidermal grafting.
引用
收藏
页码:521 / 534
页数:14
相关论文
共 120 条
[41]   HETEROGENEITY IN HORMONE RESPONSES AND PATTERNS OF COLLAGEN-SYNTHESIS IN CLONED DERMAL FIBROBLASTS [J].
GOLDRING, SR ;
STEPHENSON, ML ;
DOWNIE, E ;
KRANE, SM ;
KORN, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :798-803
[42]   FIBROBLASTS, MYOFIBROBLASTS, AND WOUND CONTRACTION [J].
GRINNELL, F .
JOURNAL OF CELL BIOLOGY, 1994, 124 (04) :401-404
[43]   Clinical effectiveness of an ointment containing prostaglandin E(1) for the treatment of burn wounds [J].
Gunji, H ;
Ono, I ;
Tateshita, T ;
Kaneko, F .
BURNS, 1996, 22 (05) :399-405
[44]  
HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060
[45]   Mechanism of action and in vivo role of platelet-derived growth factor [J].
Heldin, CH ;
Westermark, B .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1283-1316
[46]   STANOZOLOL AS A NOVEL THERAPEUTIC AGENT IN DERMATOLOGY [J].
HELFMAN, T ;
FALANGA, V .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (02) :254-258
[47]   Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers [J].
Herouy, Y ;
Hellstem, MO ;
Vanscheidt, W ;
Schöpf, E ;
Norgauer, K .
LANCET, 2000, 355 (9219) :1970-1971
[48]   ABERRANT INTEGRIN EXPRESSION DURING EPIDERMAL WOUND-HEALING AND IN PSORIATIC EPIDERMIS [J].
HERTLE, MD ;
KUBLER, MD ;
LEIGH, IM ;
WATT, FM .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (06) :1892-1901
[49]   TREATMENT OF CHRONIC EROSIONS OF JUNCTIONAL EPIDERMOLYSIS-BULLOSA WITH HUMAN EPIDERMAL ALLOGRAFTS [J].
HILL, JC ;
GRIMWOOD, RE ;
PARSONS, DS .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1992, 18 (05) :396-400
[50]  
HINMAN CD, 1963, NATURE, V200, P377, DOI [10.1038/200377a0, 10.1038/200378a0]